Delivery Order SPE2DB20D2104-SPE2DB25FMVJD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,741.91 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Cryselle-28 tablets. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion and extending through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,361.20 to AmerisourceBergen Drug Corp for Cryselle-28 tablets (28-count packaging) on December 17, 2025, with an ultimate completion date of December 18, 2025. This is a firm fixed-price, non-set-aside contract for pharmaceutical delivery to support federal medical procurement needs. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $7,221.73 to AmerisourceBergen Drug Corp for Cryselle-28 tablets on April 22, 2025, with an ultimate completion date of April 23, 2025. The contract employs firm fixed price pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of Cryselle-28 tablets, a birth control medication, with a ceiling value of $5,708.05. This is a firm fixed-price delivery order with an ultimate completion date of September 15, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $2,782.19 to AmerisourceBergen Drug Corp for Cryselle-28 tablets on October 17, 2025, with completion targeted for October 20, 2025. This firm fixed price, non-set-aside contract represents a pharmaceutical supply delivery executed through AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,702.12, is for the delivery of CRYSELLE-28 TABLET 28S medical supplies. The contract has an ultimate completion date of February 13, 2025 and is a firm fixed-price contract type. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,089.41 Firm Fixed Price Delivery Order is for the supply of CRYSELLE-28 TABLET 28S, a pharmaceutical product. The contract has a period of performance through May 6, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
- This delivery order, valued at $2,023.19, was awarded to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Cryselle 0.3-0.03 contraceptive medication. The contract is non-competitive and represents a child order under a larger Indefinite Delivery Contract vehicle with the Defense Logistics Agency Troop Support Medical. Performance will occur at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 26, 2025. This award was...
- The Defense Logistics Agency awarded a $1,173.45 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562355585 CRYSELLE-28 TABLET 28S. The delivery order is under an indefinite-delivery/indefinite-quantity contract vehicle to provide pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania from September 29, 2023 through October 2, 2023. As the prime contractor, Amerisourcebergen will be...
- This delivery order, awarded July 30, 2025, represents a $27,876.18 firm fixed-price contract issued by the Defense Logistics Agency's Medical Supply Chain division to AmerisourceBergen Drug Corp for pharmaceutical and medical supply delivery. The contract, which is a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), is scheduled for completion by August 20, 2025. The award was competitively...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMVJDDelivery Order
This delivery order, awarded July 14, 2025, represents a $7,016.52 firm fixed-price contract issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Cryselle-28 tablets. The contract is set to be completed by July 15, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award is a non-set-aside, competitively awarded contract that leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical supply vehicle valued through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to deliver diverse pharmaceutical products and medical supplies across multiple therapeutic domains through competitive procurement processes. This delivery order for Cryselle-28 tablets reflects the company's ongoing role in fulfilling DLA's pharmaceutical supply requirements for military healthcare programs, consistent with its broader mission to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 7/14/25 |